VT
vTv Therapeutics Inc.
VTVT · NASDAQ
$31.30 -0.48% (-$0.15)
1M -6.17%
Market Cap $82.3M
P/E Ratio -
Div. Yield -
ROE 6.27%
Bulios Fair Price
$38.84
24.1% upside
Trenutna cena
$31.3
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica VTVT trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
86 /100
Cheap P/B 1.05x
P/S 2.23x
EV/EBITDA N/A
Growth
-
N/A Rev. growth N/A
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 12.91%
Op. margin 25.11%
FCF margin 45.50%
Quality
5 /100
Poor ROE 6.27%
ROA 5.43%
Asset turnover 0.42x
Debt
69 /100
Low Current ratio 12.48x
Int. coverage -1,066.17x
Debt/Equity 0.00x
Stability
31 /100
Unstable EPS volatility 37.95%
Profitable years 0
Beta 0.29x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o VTVT
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Paul J. Sekhri
Employees
26
Headquarters
High Point
Prihajajoči dogodki
05 NOV.
Earnings
Upcoming earnings report